ARCHIVES

Promising Results For Glivec In CML Continue, FDA Grants Priority Review

This article is from The Cancer Letter archive.

Vol. 24 No. 4 | April 27, 2001

Download PDF Visit The Full Archive

Related Articles

NCAB Decides To End IGs, Review total Research Support, And Consider P01 Limitation

June 12, 1992

Intramural Funding To Decrease, R01s Increase, Klausner Says

September 15, 1995

Funding Opportunities (12-page issue).

May 16, 2003

Lynch Named Director, Yale Cancer Center

February 27, 2009

CREG Announcement June 1 Includes 17 Projects Worth $4.1 Million

May 16, 1975

Senate Committee Proposes $100 Million DOD Prostate Cancer Research Program

July 12, 1996